ALAMEDA, Calif. (BUSINESS WIRE) AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023.Balance Sheet InformationCash, cash equivalents, and restricted cash.
AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023.
Balance. | May 12, 2023
AgeX Therapeutics Reports First Quarter 2023 Financial Results wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.